Project
Illumina Body Map 2
Navigation
Downloads
Results for NFIX_NFIB
Z-value: 3.35
Motif logo
Transcription factors associated with NFIX_NFIB
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFIX
|
ENSG00000008441.12 | nuclear factor I X |
|
NFIB
|
ENSG00000147862.10 | nuclear factor I B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFIB | hg19_v2_chr9_-_14313893_14313984 | 0.68 | 1.7e-05 | Click! |
| NFIX | hg19_v2_chr19_+_13135790_13135811 | 0.46 | 7.9e-03 | Click! |
Activity profile of NFIX_NFIB motif
Sorted Z-values of NFIX_NFIB motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr10_-_95360983 | 14.32 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
| chr4_+_111397216 | 11.72 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
| chr1_+_171154347 | 10.93 |
ENST00000209929.7
ENST00000441535.1 |
FMO2
|
flavin containing monooxygenase 2 (non-functional) |
| chr22_-_36018569 | 10.85 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr20_+_43343886 | 10.71 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr16_-_31439735 | 8.71 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
| chr11_+_77774897 | 7.97 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
| chr21_-_31588365 | 7.76 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
| chr20_+_43343476 | 7.55 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr21_-_31588338 | 7.54 |
ENST00000286809.1
|
CLDN8
|
claudin 8 |
| chr2_-_217560248 | 7.53 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
| chr9_-_129884902 | 7.53 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
| chr3_-_12200851 | 7.45 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
| chr2_+_169659121 | 7.19 |
ENST00000397206.2
ENST00000397209.2 ENST00000421711.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr1_-_230850043 | 7.17 |
ENST00000366667.4
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
| chr12_-_8815215 | 7.01 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr1_-_116311402 | 6.88 |
ENST00000261448.5
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr20_+_56136136 | 6.88 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
| chr4_+_41614720 | 6.78 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr22_+_38864041 | 6.63 |
ENST00000216014.4
ENST00000409006.3 |
KDELR3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
| chr9_-_129885010 | 6.61 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
| chr7_-_99381884 | 6.47 |
ENST00000336411.2
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr2_-_151395525 | 6.47 |
ENST00000439275.1
|
RND3
|
Rho family GTPase 3 |
| chr12_-_8815299 | 6.35 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
| chr4_+_41614909 | 6.29 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr2_+_169658928 | 6.23 |
ENST00000317647.7
ENST00000445023.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr12_-_71003568 | 6.10 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
| chr15_-_71146480 | 6.06 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr12_+_13061894 | 6.04 |
ENST00000540125.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
| chr20_+_6748311 | 5.96 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr19_+_15783879 | 5.88 |
ENST00000551607.1
|
CYP4F12
|
cytochrome P450, family 4, subfamily F, polypeptide 12 |
| chr1_-_168698433 | 5.87 |
ENST00000367817.3
|
DPT
|
dermatopontin |
| chr1_+_150480576 | 5.83 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr17_-_10452929 | 5.81 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr11_+_1944054 | 5.74 |
ENST00000397301.1
ENST00000397304.2 ENST00000446240.1 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr1_+_150480551 | 5.72 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
| chr1_+_110009215 | 5.72 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
| chr19_-_17375527 | 5.67 |
ENST00000431146.2
ENST00000594190.1 |
USHBP1
|
Usher syndrome 1C binding protein 1 |
| chr5_-_78365437 | 5.57 |
ENST00000380311.4
ENST00000540686.1 ENST00000255189.3 |
DMGDH
|
dimethylglycine dehydrogenase |
| chr3_-_46608010 | 5.56 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
| chr1_-_201398985 | 5.56 |
ENST00000336092.4
|
TNNI1
|
troponin I type 1 (skeletal, slow) |
| chr10_+_115312766 | 5.51 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
| chr1_-_209792111 | 5.47 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
| chr1_-_26394114 | 5.45 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
| chr2_+_234545148 | 5.38 |
ENST00000373445.1
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10 |
| chr2_-_152382500 | 5.37 |
ENST00000434685.1
|
NEB
|
nebulin |
| chr12_+_119616447 | 5.32 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr11_-_2170786 | 5.31 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr5_+_42423872 | 5.25 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
| chr12_-_9268819 | 5.20 |
ENST00000404455.2
|
A2M
|
alpha-2-macroglobulin |
| chr11_-_35547151 | 5.20 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr20_+_43343517 | 5.12 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr5_+_147443534 | 5.10 |
ENST00000398454.1
ENST00000359874.3 ENST00000508733.1 ENST00000256084.7 |
SPINK5
|
serine peptidase inhibitor, Kazal type 5 |
| chr1_+_153600869 | 5.10 |
ENST00000292169.1
ENST00000368696.3 ENST00000436839.1 |
S100A1
|
S100 calcium binding protein A1 |
| chr2_+_234545092 | 5.06 |
ENST00000344644.5
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10 |
| chr17_+_41005283 | 5.06 |
ENST00000592999.1
|
AOC3
|
amine oxidase, copper containing 3 |
| chr7_+_37960163 | 5.02 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
| chr4_-_16077741 | 5.02 |
ENST00000447510.2
ENST00000540805.1 ENST00000539194.1 |
PROM1
|
prominin 1 |
| chr19_-_45826125 | 4.97 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chrX_+_46937745 | 4.94 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr3_-_149293990 | 4.92 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chr6_+_132129151 | 4.90 |
ENST00000360971.2
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| chr3_+_45067659 | 4.90 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
| chr20_+_36974759 | 4.89 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr20_+_44098385 | 4.88 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr11_+_27062502 | 4.83 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr12_+_52626898 | 4.82 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr16_+_57406368 | 4.80 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
| chr7_-_99277610 | 4.62 |
ENST00000343703.5
ENST00000222982.4 ENST00000439761.1 ENST00000339843.2 |
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5 |
| chr10_-_97200772 | 4.62 |
ENST00000371241.1
ENST00000354106.3 ENST00000371239.1 ENST00000361941.3 ENST00000277982.5 ENST00000371245.3 |
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr20_+_44098346 | 4.61 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr3_-_49170405 | 4.57 |
ENST00000305544.4
ENST00000494831.1 |
LAMB2
|
laminin, beta 2 (laminin S) |
| chr12_-_15038779 | 4.56 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
| chr10_-_75401500 | 4.55 |
ENST00000359322.4
|
MYOZ1
|
myozenin 1 |
| chr1_-_151798546 | 4.54 |
ENST00000356728.6
|
RORC
|
RAR-related orphan receptor C |
| chr3_+_148457585 | 4.52 |
ENST00000402260.1
|
AGTR1
|
angiotensin II receptor, type 1 |
| chr1_+_233749739 | 4.50 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
| chr2_-_211179883 | 4.50 |
ENST00000352451.3
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
| chr15_+_74466012 | 4.46 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
| chr1_+_209878182 | 4.45 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr1_+_110009150 | 4.38 |
ENST00000401021.3
|
SYPL2
|
synaptophysin-like 2 |
| chr3_-_49170522 | 4.35 |
ENST00000418109.1
|
LAMB2
|
laminin, beta 2 (laminin S) |
| chr18_+_29171689 | 4.33 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr11_-_107590383 | 4.32 |
ENST00000525934.1
ENST00000531293.1 |
SLN
|
sarcolipin |
| chr10_+_88728189 | 4.30 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
| chr15_+_84322827 | 4.27 |
ENST00000286744.5
ENST00000567476.1 |
ADAMTSL3
|
ADAMTS-like 3 |
| chr7_+_116165038 | 4.24 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr9_-_95298254 | 4.23 |
ENST00000444490.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
| chr2_+_79347577 | 4.21 |
ENST00000233735.1
|
REG1A
|
regenerating islet-derived 1 alpha |
| chr2_+_217498105 | 4.20 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
| chr1_+_162351503 | 4.17 |
ENST00000458626.2
|
C1orf226
|
chromosome 1 open reading frame 226 |
| chr3_-_50340996 | 4.15 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr4_+_169575875 | 4.14 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr5_+_145316120 | 4.13 |
ENST00000359120.4
|
SH3RF2
|
SH3 domain containing ring finger 2 |
| chr3_+_8775466 | 4.13 |
ENST00000343849.2
ENST00000397368.2 |
CAV3
|
caveolin 3 |
| chr16_-_2004683 | 4.10 |
ENST00000268661.7
|
RPL3L
|
ribosomal protein L3-like |
| chr16_-_46797149 | 4.10 |
ENST00000536476.1
|
MYLK3
|
myosin light chain kinase 3 |
| chr17_+_37821593 | 4.10 |
ENST00000578283.1
|
TCAP
|
titin-cap |
| chr12_-_9268707 | 4.09 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
| chr10_+_124221036 | 4.09 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr11_+_12399071 | 4.08 |
ENST00000539723.1
ENST00000550549.1 |
PARVA
|
parvin, alpha |
| chr10_+_123970670 | 4.07 |
ENST00000496913.2
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr7_+_141490017 | 4.05 |
ENST00000247883.4
|
TAS2R5
|
taste receptor, type 2, member 5 |
| chr17_+_4854375 | 4.05 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
| chr7_-_99569468 | 4.04 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr11_+_18287721 | 4.01 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
| chr3_-_52488048 | 3.99 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
| chr14_+_95047725 | 3.99 |
ENST00000554760.1
ENST00000554866.1 ENST00000329597.7 ENST00000556775.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
| chr7_-_16844611 | 3.90 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
| chr17_+_59477233 | 3.89 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
| chr17_-_39769005 | 3.89 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr9_+_6215799 | 3.87 |
ENST00000417746.2
ENST00000456383.2 |
IL33
|
interleukin 33 |
| chr4_+_24797085 | 3.86 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
| chr3_-_184971853 | 3.86 |
ENST00000231887.3
|
EHHADH
|
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
| chr11_+_47608198 | 3.85 |
ENST00000356737.2
ENST00000538490.1 |
FAM180B
|
family with sequence similarity 180, member B |
| chr17_+_37784749 | 3.85 |
ENST00000394265.1
ENST00000394267.2 |
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
| chr5_+_78365577 | 3.84 |
ENST00000518666.1
ENST00000521567.1 |
BHMT2
|
betaine--homocysteine S-methyltransferase 2 |
| chr8_+_9009296 | 3.82 |
ENST00000521718.1
|
RP11-10A14.4
|
Uncharacterized protein |
| chr1_+_86046433 | 3.82 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
| chr17_-_67224812 | 3.81 |
ENST00000423818.2
|
ABCA10
|
ATP-binding cassette, sub-family A (ABC1), member 10 |
| chr16_-_20556492 | 3.79 |
ENST00000568098.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
| chr3_-_149688655 | 3.78 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
| chr12_+_72667203 | 3.77 |
ENST00000547300.1
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
| chr3_-_149093499 | 3.77 |
ENST00000472441.1
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr10_-_104597286 | 3.73 |
ENST00000369887.3
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1 |
| chr6_-_39902160 | 3.73 |
ENST00000340692.5
|
MOCS1
|
molybdenum cofactor synthesis 1 |
| chr3_+_29322437 | 3.73 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
| chr1_-_79472365 | 3.72 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
| chr9_-_97356075 | 3.72 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
| chr12_-_52911718 | 3.71 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
| chr12_-_91505608 | 3.71 |
ENST00000266718.4
|
LUM
|
lumican |
| chr1_+_201159914 | 3.70 |
ENST00000335211.4
ENST00000451870.2 ENST00000295591.8 |
IGFN1
|
immunoglobulin-like and fibronectin type III domain containing 1 |
| chr2_+_120187465 | 3.70 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
| chr11_+_27062860 | 3.69 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr15_-_35088340 | 3.69 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
| chr10_-_93392811 | 3.68 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr15_+_96873921 | 3.68 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr12_-_8815404 | 3.67 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
| chr19_-_36247910 | 3.65 |
ENST00000587965.1
ENST00000004982.3 |
HSPB6
|
heat shock protein, alpha-crystallin-related, B6 |
| chr6_+_160769399 | 3.64 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
| chr1_-_203144941 | 3.61 |
ENST00000255416.4
|
MYBPH
|
myosin binding protein H |
| chr3_-_189840223 | 3.61 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
| chr5_-_36301984 | 3.60 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
| chr11_+_114166536 | 3.60 |
ENST00000299964.3
|
NNMT
|
nicotinamide N-methyltransferase |
| chr10_+_99332198 | 3.55 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr11_+_114168773 | 3.55 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
| chr1_-_204183071 | 3.52 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
| chr11_+_57310114 | 3.49 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
| chr14_+_95047744 | 3.49 |
ENST00000553511.1
ENST00000554633.1 ENST00000555681.1 ENST00000554276.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
| chr1_-_116311323 | 3.49 |
ENST00000456138.2
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr7_-_94953878 | 3.48 |
ENST00000222381.3
|
PON1
|
paraoxonase 1 |
| chr1_-_22263790 | 3.48 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr22_+_24577183 | 3.47 |
ENST00000358321.3
|
SUSD2
|
sushi domain containing 2 |
| chr7_-_135433534 | 3.46 |
ENST00000338588.3
|
FAM180A
|
family with sequence similarity 180, member A |
| chr1_+_1370903 | 3.46 |
ENST00000338660.5
ENST00000404702.3 ENST00000476993.1 ENST00000471398.1 |
VWA1
|
von Willebrand factor A domain containing 1 |
| chr7_-_73038822 | 3.46 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr1_+_47533160 | 3.44 |
ENST00000334194.3
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
| chr1_+_207277632 | 3.42 |
ENST00000421786.1
|
C4BPA
|
complement component 4 binding protein, alpha |
| chr13_+_31480328 | 3.42 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
| chr17_-_66951474 | 3.41 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
| chr11_+_34654011 | 3.41 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
| chr11_+_71903169 | 3.40 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
| chr19_+_45281118 | 3.39 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr19_-_42947121 | 3.38 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr15_+_71839566 | 3.38 |
ENST00000357769.4
|
THSD4
|
thrombospondin, type I, domain containing 4 |
| chr9_-_114361665 | 3.38 |
ENST00000309195.5
|
PTGR1
|
prostaglandin reductase 1 |
| chr3_+_174158732 | 3.36 |
ENST00000434257.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
| chr11_+_34642656 | 3.36 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
| chrX_+_46940254 | 3.35 |
ENST00000336169.3
|
RGN
|
regucalcin |
| chr3_+_42727011 | 3.35 |
ENST00000287777.4
|
KLHL40
|
kelch-like family member 40 |
| chr13_-_44735393 | 3.34 |
ENST00000400419.1
|
SMIM2
|
small integral membrane protein 2 |
| chr7_-_99381798 | 3.34 |
ENST00000415003.1
ENST00000354593.2 |
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr1_+_47264711 | 3.33 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
| chr12_+_53443963 | 3.32 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr11_-_119247004 | 3.32 |
ENST00000531070.1
|
USP2
|
ubiquitin specific peptidase 2 |
| chr2_-_238499725 | 3.31 |
ENST00000264601.3
|
RAB17
|
RAB17, member RAS oncogene family |
| chr1_+_101185290 | 3.31 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
| chr14_-_38725573 | 3.31 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
| chr6_-_39197226 | 3.31 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
| chr17_+_68100989 | 3.31 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr7_-_73038867 | 3.31 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
| chr11_+_75428857 | 3.31 |
ENST00000198801.5
|
MOGAT2
|
monoacylglycerol O-acyltransferase 2 |
| chr1_-_27240455 | 3.30 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
| chr4_-_88450612 | 3.26 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
| chr1_-_171621815 | 3.26 |
ENST00000037502.6
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response |
| chr14_-_23876801 | 3.22 |
ENST00000356287.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
| chr3_-_184971817 | 3.22 |
ENST00000440662.1
ENST00000456310.1 |
EHHADH
|
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
| chr17_-_15168624 | 3.22 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
| chr9_+_74764340 | 3.21 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
| chr16_+_57406437 | 3.21 |
ENST00000564948.1
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
| chr11_-_61687739 | 3.20 |
ENST00000531922.1
ENST00000301773.5 |
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
| chr1_-_153585539 | 3.17 |
ENST00000368706.4
|
S100A16
|
S100 calcium binding protein A16 |
| chr8_-_23712312 | 3.16 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
| chr8_+_92261516 | 3.15 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
| chr16_+_55522536 | 3.15 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr3_-_58613323 | 3.15 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr10_+_5238793 | 3.14 |
ENST00000263126.1
|
AKR1C4
|
aldo-keto reductase family 1, member C4 |
| chr11_-_47206965 | 3.14 |
ENST00000525725.1
|
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
| chr11_+_18287801 | 3.14 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
| chr9_+_69650263 | 3.10 |
ENST00000322495.3
|
AL445665.1
|
Protein LOC100996643 |
Network of associatons between targets according to the STRING database.
First level regulatory network of NFIX_NFIB
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 14.0 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 3.9 | 15.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 3.5 | 10.5 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 3.1 | 9.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 3.0 | 8.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 2.7 | 10.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 2.6 | 5.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 2.5 | 15.0 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 2.5 | 12.3 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.4 | 14.6 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 2.4 | 14.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 2.3 | 6.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 2.2 | 20.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 2.2 | 11.0 | GO:1904640 | response to methionine(GO:1904640) |
| 2.1 | 4.3 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 2.1 | 2.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 2.1 | 10.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 2.1 | 6.2 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 2.0 | 6.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.8 | 5.5 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.8 | 5.5 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 1.8 | 5.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.8 | 7.1 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 1.7 | 1.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 1.7 | 6.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 1.6 | 4.9 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 1.6 | 6.5 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 1.6 | 4.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 1.6 | 1.6 | GO:0043491 | protein kinase B signaling(GO:0043491) |
| 1.6 | 7.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.6 | 15.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 1.6 | 14.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.5 | 4.6 | GO:0097187 | dentinogenesis(GO:0097187) |
| 1.5 | 9.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.5 | 6.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.5 | 6.0 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.5 | 4.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.4 | 4.3 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 1.4 | 5.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.4 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.4 | 8.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 1.4 | 1.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 1.4 | 5.6 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 1.4 | 5.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.4 | 4.2 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 1.4 | 5.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.4 | 8.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.4 | 8.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 1.4 | 2.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.4 | 1.4 | GO:0016107 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.3 | 9.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 1.3 | 4.0 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.3 | 9.3 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 1.3 | 9.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 1.3 | 10.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.2 | 3.7 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 1.2 | 1.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
| 1.2 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
| 1.2 | 3.6 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 1.2 | 1.2 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 1.2 | 4.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.1 | 4.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
| 1.1 | 6.8 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 1.1 | 5.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.1 | 3.4 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.1 | 1.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 1.1 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 1.1 | 1.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.1 | 4.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 1.1 | 4.4 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 1.1 | 3.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.1 | 14.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.1 | 5.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 1.1 | 9.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.1 | 5.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 1.1 | 3.2 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.1 | 4.3 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.1 | 5.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.1 | 2.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.1 | 5.3 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.0 | 3.1 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
| 1.0 | 4.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.0 | 4.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 1.0 | 11.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.0 | 5.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.0 | 4.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.0 | 1.0 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.0 | 5.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 1.0 | 2.9 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 1.0 | 2.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.0 | 2.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.0 | 3.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.9 | 2.8 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.9 | 5.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.9 | 6.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.9 | 1.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.9 | 5.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.9 | 6.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.9 | 4.6 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.9 | 2.7 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.9 | 1.8 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.9 | 2.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.9 | 8.1 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 0.9 | 2.7 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.9 | 12.4 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.9 | 3.5 | GO:2001250 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.9 | 8.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.9 | 3.4 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.8 | 2.5 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 0.8 | 6.7 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.8 | 3.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.8 | 12.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.8 | 4.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.8 | 4.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.8 | 0.8 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.8 | 5.8 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.8 | 8.9 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.8 | 2.4 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.8 | 3.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.8 | 1.6 | GO:0048627 | myoblast development(GO:0048627) |
| 0.8 | 8.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.8 | 6.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.8 | 3.2 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.8 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.8 | 4.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.8 | 1.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.8 | 2.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.8 | 9.5 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.8 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.8 | 5.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.8 | 0.8 | GO:1901660 | calcium ion export(GO:1901660) |
| 0.8 | 3.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.8 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.8 | 6.9 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.8 | 26.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.8 | 6.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 0.8 | 2.3 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.7 | 2.2 | GO:0090265 | response to high density lipoprotein particle(GO:0055099) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
| 0.7 | 12.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.7 | 3.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.7 | 8.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.7 | 2.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.7 | 3.7 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.7 | 2.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.7 | 8.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.7 | 2.9 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.7 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.7 | 1.4 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.7 | 5.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.7 | 1.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.7 | 1.4 | GO:0055001 | muscle cell development(GO:0055001) |
| 0.7 | 13.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.7 | 3.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.7 | 5.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.7 | 2.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.7 | 2.1 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.7 | 1.4 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.7 | 1.4 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.7 | 5.5 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.7 | 39.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.7 | 4.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.7 | 0.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.7 | 5.4 | GO:0046618 | drug export(GO:0046618) |
| 0.7 | 2.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 | 9.3 | GO:0015705 | iodide transport(GO:0015705) |
| 0.7 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.7 | 1.3 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.7 | 3.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.6 | 9.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.6 | 3.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.6 | 1.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.6 | 1.9 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.6 | 5.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 | 1.3 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.6 | 2.5 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.6 | 0.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.6 | 1.9 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.6 | 4.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.6 | 5.0 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.6 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 | 5.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 3.1 | GO:1990035 | inorganic cation import into cell(GO:0098659) calcium ion import across plasma membrane(GO:0098703) inorganic ion import into cell(GO:0099587) calcium ion import into cell(GO:1990035) |
| 0.6 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 | 3.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.6 | 0.6 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.6 | 1.9 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 | 1.9 | GO:0060279 | negative regulation of B cell differentiation(GO:0045578) positive regulation of ovulation(GO:0060279) |
| 0.6 | 1.9 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.6 | 1.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.6 | 1.8 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.6 | 5.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.6 | 7.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.6 | 4.3 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.6 | 3.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 | 2.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 4.8 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.6 | 3.6 | GO:0097435 | fibril organization(GO:0097435) |
| 0.6 | 1.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.6 | 19.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.6 | 10.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.6 | 0.6 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
| 0.6 | 10.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.6 | 10.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.6 | 3.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.6 | 1.7 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.6 | 2.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.6 | 3.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.6 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.6 | 2.3 | GO:0060262 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.6 | 6.8 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 0.6 | 1.7 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.6 | 9.0 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.6 | 5.6 | GO:1990834 | response to odorant(GO:1990834) |
| 0.6 | 7.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.6 | 3.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.6 | 2.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.6 | 2.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.5 | 6.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.5 | 1.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.5 | 1.6 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.5 | 2.2 | GO:0033685 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.5 | 20.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.5 | 2.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.5 | 11.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.5 | 3.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.5 | 6.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.5 | 1.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.5 | 3.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.5 | 5.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.5 | 6.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.5 | 1.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.5 | 2.6 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.5 | 0.5 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 0.5 | 2.5 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.5 | 2.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 3.5 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.5 | 3.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 | 3.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.5 | 3.0 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.5 | 1.5 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) inner ear receptor cell differentiation(GO:0060113) |
| 0.5 | 1.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.5 | 2.0 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.5 | 5.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.5 | 1.5 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.5 | 0.5 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.5 | 2.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.5 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.5 | 11.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.5 | 6.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.5 | 4.3 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.5 | 2.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.5 | 5.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.5 | 6.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.5 | 1.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.5 | 8.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.5 | 2.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 | 1.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.5 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.5 | 0.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.5 | 7.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.5 | 2.8 | GO:0015853 | adenine transport(GO:0015853) |
| 0.5 | 1.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.5 | 5.5 | GO:0060068 | vagina development(GO:0060068) |
| 0.5 | 1.4 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.5 | 1.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.5 | 3.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.5 | 6.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.5 | 0.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 | 3.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.5 | 20.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.5 | 3.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.5 | 23.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.4 | 3.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.4 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.4 | 0.4 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.4 | 1.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.4 | 10.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 11.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 | 11.8 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.4 | 1.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.4 | 1.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.4 | 4.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.4 | 5.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 1.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.4 | 2.2 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.4 | 2.2 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.4 | 3.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.4 | 13.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 | 3.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.4 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.4 | 4.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.4 | 1.3 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 | 2.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 3.4 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.4 | 12.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 1.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.4 | 2.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.4 | 2.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.4 | 0.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.4 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.4 | 1.6 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.4 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.4 | 1.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.4 | 9.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.4 | 2.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.4 | 8.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 1.6 | GO:0018277 | protein deamination(GO:0018277) |
| 0.4 | 4.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 | 2.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.4 | 1.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.4 | 1.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.4 | 0.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.4 | 1.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.4 | 1.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.4 | 0.8 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 1.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.4 | 1.2 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.4 | 2.4 | GO:0006863 | purine nucleobase transport(GO:0006863) nucleobase transport(GO:0015851) |
| 0.4 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.4 | 1.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 | 9.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.4 | 5.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.4 | 1.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.4 | 4.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.4 | 1.5 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.4 | 1.5 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.4 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 | 2.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.4 | 1.5 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 11.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.4 | 1.9 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.4 | 5.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.4 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.4 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.4 | 0.7 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.4 | 5.1 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.4 | 2.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 | 2.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 6.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.4 | 4.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 1.8 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.4 | 1.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.4 | 12.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.4 | 1.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
| 0.4 | 1.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.3 | 8.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.3 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.3 | 0.7 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 | 1.0 | GO:2000259 | positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.3 | 1.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 | 1.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.3 | 2.4 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.3 | 2.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.3 | 1.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.3 | 1.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 | 2.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 | 3.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.3 | 0.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.3 | 1.7 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.3 | 1.7 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.3 | 1.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 3.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 4.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.3 | 2.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 | 1.0 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.3 | 4.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.3 | 4.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 7.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 | 11.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.3 | 2.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 5.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.3 | 0.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 0.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.3 | 1.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
| 0.3 | 1.0 | GO:0019516 | lactate oxidation(GO:0019516) |
| 0.3 | 2.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.3 | 6.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.3 | 1.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.3 | 1.3 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 0.3 | 6.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.3 | 3.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.3 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 1.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.3 | 1.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 6.8 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.3 | 2.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.3 | 1.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.3 | 3.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.3 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.3 | 0.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.3 | 0.9 | GO:0008306 | associative learning(GO:0008306) |
| 0.3 | 0.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.3 | 0.3 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.3 | 5.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.3 | 2.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 | 2.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.3 | 1.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.3 | 0.3 | GO:0048372 | lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.3 | 1.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.3 | 8.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 3.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 2.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 2.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 0.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.3 | 11.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.3 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.3 | 1.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.3 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 1.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.3 | 1.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.3 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.3 | 0.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.3 | 0.8 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.3 | 0.8 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.3 | 1.1 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.3 | 1.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.3 | 0.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.3 | 5.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.8 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 | 2.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.3 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.3 | 2.7 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 | 2.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 0.8 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.3 | 1.6 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.3 | 1.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 3.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.3 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.3 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 | 1.3 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.3 | 1.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 0.8 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.3 | 0.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 0.8 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.3 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.3 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 4.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.3 | 5.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 2.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.2 | 2.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 | 2.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimul |